FDA panel rejects GlaxoSmithKline vaccine

The FDA's Vaccine and Related Biological Products Advisory Committee recommended 6-to-5, with one abstension, against approval of GSK's Infanrix DTaP-HepB-IPV to prevent diphtheria, tetanus, pertussis...